I thought this was interesting - new study looking at the risk/benefit balance of vaccinating 12-17 year olds. They look at the effects of two doses, but I'm guessing the risk/benefit would be similar for one dose.
www.medscape.com/viewarticle/959989?uac=86421BJ&faf=1&sso=true&impID=3676156&src=WNL_newsalert_uk_210930mscpedit_gen
The new study saw researchers conduct a risk/benefit analysis of teenagers aged 12 to 17 getting both doses of the vaccine. Researchers used historic rates of hospital admission, intensive care support and death among children in England who had COVID-19. They also examined estimates of long COVID and looked at vaccine efficacy rates and the potential risk of heart inflammation linked to the jab, also known as vaccine-induced myocarditis.
Their study, published in the Journal of the Royal Society of Medicine, suggests the benefits of getting a second jab outweigh the risks "unless case rates are sustainably low".
The benefit of vaccination in terms of hospitalisations in adolescents outweighs risks unless case rates are sustainably very low.
The study also suggests that thousands of potential cases of long COVID could be averted.